Fund shareholders of Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd
ISIN CNE1000000W4 · China · LEI 30030088QF1YDN4MLL89
- Fund shareholders
- 7
- Of which ETFs
- 3 4 other funds
- Value held
- 543.7K $
| Fund | Shares | Value | Weight in fund | |
|---|---|---|---|---|
| EMERGING MARKETS CORE EQUITY 2 PORTFOLIO DFA INVESTMENT DIMENSIONS GROUP INC | 632,000 | 229.2K $ | 0.00 % | as of Apr 30, 2026 ↗ |
| THE EMERGING MARKETS SMALL CAP SERIES DFA INVESTMENT TRUST CO | 347,000 | 125.9K $ | 0.00 % | as of Apr 30, 2026 ↗ |
| Dimensional Emerging Core Equity Market ETF Dimensional ETF Trust | 196,000 | 71.1K $ | 0.00 % | as of Apr 30, 2026 ↗ |
| Dimensional Emerging Markets Core Equity 2 ETF Dimensional ETF Trust | 130,000 | 47.1K $ | 0.00 % | as of Apr 30, 2026 ↗ |
| Emerging Markets Social Core Equity Portfolio DFA INVESTMENT DIMENSIONS GROUP INC | 81,000 | 29.4K $ | 0.00 % | as of Apr 30, 2026 ↗ |
| Dimensional World ex. U.S. Core Equity 2 ETF Dimensional ETF Trust | 79,000 | 28.6K $ | 0.00 % | as of Apr 30, 2026 ↗ |
| World ex U.S. Core Equity Portfolio DFA INVESTMENT DIMENSIONS GROUP INC | 34,000 | 12.3K $ | 0.00 % | as of Apr 30, 2026 ↗ |
The funds most exposed to it
The weight is the share of a fund's net assets. The holders table ranks funds by number of shares. This one ranks them by the weight of the company in each fund.
| Fund | Weight in fund | |
|---|---|---|
| THE EMERGING MARKETS SMALL CAP SERIES DFA INVESTMENT TRUST CO | 0.00 % | as of Apr 30, 2026 ↗ |
| Emerging Markets Social Core Equity Portfolio DFA INVESTMENT DIMENSIONS GROUP INC | 0.00 % | as of Apr 30, 2026 ↗ |
| Dimensional Emerging Core Equity Market ETF Dimensional ETF Trust | 0.00 % | as of Apr 30, 2026 ↗ |
| Dimensional Emerging Markets Core Equity 2 ETF Dimensional ETF Trust | 0.00 % | as of Apr 30, 2026 ↗ |
| EMERGING MARKETS CORE EQUITY 2 PORTFOLIO DFA INVESTMENT DIMENSIONS GROUP INC | 0.00 % | as of Apr 30, 2026 ↗ |
| Dimensional World ex. U.S. Core Equity 2 ETF Dimensional ETF Trust | 0.00 % | as of Apr 30, 2026 ↗ |
| World ex U.S. Core Equity Portfolio DFA INVESTMENT DIMENSIONS GROUP INC | 0.00 % | as of Apr 30, 2026 ↗ |
Quarter after quarter
Each row is one quarter of SEC filings, newest first. The change compares each quarter with the one before.
| Quarter | Shareholders | Change | Shares | Change |
|---|---|---|---|---|
| 2026Q2 | 7 | 0 | 1,499,000 | +2.7 % |
| 2026Q1 | 7 | 0 | 1,459,000 | -3.7 % |
| 2025Q4 | 7 | +2 | 1,515,000 | +23.0 % |
| 2025Q3 | 5 | 0 | 1,232,000 | +23.1 % |
| 2025Q2 | 5 | +1 | 1,001,000 | -20.7 % |
| 2025Q1 | 4 | 0 | 1,263,000 | -45.7 % |
| 2024Q4 | 4 | -5 | 2,326,000 | -28.4 % |
| 2024Q3 | 9 | -1 | 3,249,000 | -4.4 % |
| 2024Q2 | 10 | 0 | 3,400,000 | -3.5 % |
| 2024Q1 | 10 | -4 | 3,523,000 | -17.9 % |
| 2023Q4 | 14 | 4,291,157 |
Cite this page
Titelia. "Fund shareholders of Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd". https://titelia.com/en/stocks/shanghai-fudan-zhangjiang-bio-pharmaceutical-co-ltd-CNE1000000W4